Side-by-side comparison
| Topic | Oligio | Ultraformer |
|---|---|---|
| Manufacturer | Wontech, South Korea | Classys, South Korea |
| Technology | Monopolar radiofrequency (RF) | High-intensity focused ultrasound (HIFU) |
| Energy pattern | RF current produces broader, impedance-dependent heating between the treatment tip and return pad | Cartridges concentrate ultrasound into small thermal zones at selected nominal focal depths |
| Built-in tissue image | No ultrasound image; delivery uses tip contact, cooling and device feedback | No live tissue image; cartridge choice and anatomy-based placement guide the plan |
| Typical discussion | Early diffuse laxity and skin firmness where a broader heating pattern may fit | Mild-to-moderate laxity where a focal, depth-selected ultrasound plan may fit |
| Planned downtime | Usually little; redness, swelling, tenderness or a heat reaction can occur | Usually little; redness, swelling, tenderness or altered sensation can occur |
| Package unit | Often sold by “shots” | Often sold by “shots”; model and mode change what that word represents |
How the energy patterns differ
Oligio sends monopolar RF energy from a disposable tip through tissue to a return pad. The system cools the epidermis while RF delivery creates a broader heated volume. Contact, impedance, tip condition, passes and settings all influence where and how heat builds. This is Oligio by Wontech — not a Classys device.
Ultraformer uses Classys HIFU cartridges to create discrete thermal zones at nominal focal depths. The operator chooses the cartridge, mode, energy and placement for each area. A depth printed on a cartridge is a device specification, not proof that every shot lands in one named facial layer: tissue thickness and anatomy vary by person and location. Ultraformer is not Ulthera, has no Ulthera-style live imaging and is not made by Merz.
Which concerns may fit each one?
- Oligio may enter the discussion when the goal is improving skin firmness or early, relatively diffuse laxity with a broader monopolar-RF heating plan.
- Ultraformer may enter the discussion when mild-to-moderate laxity or facial-outline change could suit focal ultrasound placement at more than one planned depth.
- Neither is a diagnosis. A soft jawline can reflect skin laxity, facial fat, volume loss, muscle, bone structure or several of these at once.
Neither device should be promised as predictable facial-fat removal, a replacement for lost volume or an alternative equal to surgery. A thin or hollow face is not an automatic vote for RF, and a fuller face is not an automatic vote for HIFU. The treatment map and areas deliberately left untreated matter as much as the device name.
Comfort and downtime
Oligio is usually felt as repeated warmth or hot pulses; its contact cooling and vibration are designed to improve tolerability. Ultraformer can feel prickly, sharp, tingling or deeply achy depending on the cartridge, setting and area. Pain varies widely, and there is no direct Oligio-versus-Ultraformer trial that proves one is always more comfortable.
Both usually involve little planned downtime, but “no downtime” is marketing shorthand — not a safety guarantee. Temporary redness, swelling or tenderness can follow either treatment. Ultraformer may also cause temporary numbness or tingling. A burn, blister, persistent contour change, marked weakness or worsening neurological symptom needs prompt assessment rather than routine aftercare.
What the evidence can support
The cited Oligio study followed 30 Thai volunteers with mild-to-moderate lower-face laxity after one treatment for six months. Most improvement was graded mild to moderate; immediate redness was common and resolved within one or two days, and no serious adverse event was reported. That is useful device-specific evidence, but it is a small, uncontrolled cohort — not a guarantee of outcome, duration or repeat schedule.
The cited Ultraformer MPT report measured 50 patients with three-dimensional imaging immediately before and after treatment. It found regional changes, but it had no randomized comparator and no long-term follow-up for durability. Evidence from Ultraformer III, Ultraformer MPT, other HIFU systems or other monopolar-RF machines should not be pooled as though the devices and protocols were identical.
We did not identify a direct randomized Oligio-versus-Ultraformer trial. A technology-level trial of other monopolar-RF and focused-ultrasound systems can help frame the mechanisms, but it cannot declare a winner between these two brands. There is therefore no evidence-safe fixed number of sessions, fixed duration or universal “better” choice.
Risks, contraindications and authorization
Oligio can cause redness, swelling and tenderness; excessive or uneven RF heating can cause thermal injury, including burns. A pacemaker, implanted defibrillator or another active implanted electronic device is an absolute contraindication to Oligio monopolar RF. This is not solved by moving the return pad. Tell the doctor before booking, not after arriving for treatment.
Ultraformer uses a different energy source, so the monopolar-RF circuit rationale should not be copied — but implants are not automatically acceptable. The Ultraformer MPT IFU independently lists implantable electrical devices, treatment-area metal stents or electrical implants, and bioabsorbable mechanical implants among conditions for which treatment is not recommended. It also lists pregnancy or breastfeeding, open wounds or lesions, an active systemic or local skin disease that may alter wound healing, a skin infection of any type, severe or cystic acne in the treatment area, and hemorrhagic disorders. Lists vary by model, so the exact IFU controls. Tell the clinician about previous surgery and recent fillers or threads so they can be assessed separately during treatment planning; these are not universal contraindications unless the exact model instructions say so. Classys also instructs operators to avoid named nerve areas and stop treating a site if undue pain or tingling occurs.
Authorization is also device- and country-specific. The US FDA 510(k) summary for The Oligio names Wontech and describes RF delivery with epidermal cooling, but its stated US indication is electrocoagulation and hemostasis of soft tissue — not a blanket cosmetic-lifting clearance. Korea’s MFDS listing names Classys and gives Ultraformer III an intended use of eyebrow lifting. Neither record proves Thai registration, every advertised treatment area or authorization of another model. Ask for the exact model and verify its Thai FDA record.
Why shot counts do not convert
An Oligio shot is an RF pulse delivered through a treatment tip over an area. An Ultraformer shot is a focused-ultrasound emission whose pattern also depends on the model, cartridge and mode. Even though clinics may use the same word, the units do not represent the same energy, tissue volume or coverage.
Do not convert Oligio shots into Ultraformer shots — and do not equate either with the “lines” sold for another ultrasound system. Ask which areas will be treated, which tip or cartridge and mode will be used, how passes or spacing are planned, what will be avoided and what clinical endpoint the doctor is aiming for.
Decision checklist
- What is the main issue: skin firmness, laxity, fat, volume loss, muscle or structural anatomy?
- Which exact machine and model is being proposed, and can the clinic show that it is genuine and registered in Thailand?
- Why does the proposed energy pattern fit this concern and treatment area?
- For Oligio: how will the tip, return pad, cooling, contact and passes be managed — and has active electronic-implant screening been completed?
- For Ultraformer: which cartridge, mode and nominal depth will be used, and which nerve, bone, implant or hollow areas will be avoided?
- What improvement is realistic, what will the device not fix, and what is the plan if the response is weak or a complication occurs?
The bottom line
Oligio and Ultraformer solve the “lifting” question with different energy patterns: broader monopolar-RF heating from Wontech versus focused ultrasound from Classys. Oligio may fit a firmness-led plan; Ultraformer may fit a focal, depth-selected laxity plan. That is a starting point, not a verdict. Choose the diagnosis, treatment map, contraindication screening and operator judgment before choosing the biggest shot package.